Anatomic Stage IIIA Breast Cancer AJCC v8 Completed Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0109626 (Anatomic Stage IIIA Breast Cancer AJCC v8)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03872388Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant ChemotherapyTreatment